← Tutti gli studi
Interventi psicologici
Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
Winkley K, et al. · 2020
PubMed 32568666 ↗DOI: 10.3310/hta24280Health technology assessment (Winchester, England)
🌱 La lettura di LEO
🧠 Lavora su: Mente & vita · lente Traiettoria · il corpo nel tempo
tocca anche 📉 Stabilità nel tempo
Revisione sistematica e meta-analisi a rete (HTA NIHR; certezza moderata)
La domandaGli interventi psicologici (es. terapia cognitivo-comportamentale, counselling, terapia familiare, psicoterapia) migliorano l'autogestione e il controllo glicemico nelle persone con diabete di tipo 1 e di tipo 2?
Cosa hanno trovato96 studi inclusi (n=18.659). Meta-analisi a effetti casuali su HbA1c: adulti T1DM 7 studi (n=851) differenza media aggregata -0,13 (IC 95% da -0,33 a 0,07), riduzione NON significativa; bambini/adolescenti T1DM 18 studi (n=2.583) MD 0,00 (IC 95% da -0,18 a 0,18), nessun cambiamento; adulti T2DM 49 studi (n=12.009) MD -0,21 (IC 95% da -0,31 a -0,10), equivalente a -0,33% di HbA1c ovvero circa 3,5 mmol/mol. Nel T2DM miglioramento di comportamento alimentare e qualita di vita, ma NON di pressione arteriosa, BMI o sintomi depressivi. Meta-analisi a rete: adulti T1DM (7 studi, 968) attention control e TCC efficaci, TCC costo-efficace; adulti T2DM (49 studi, 12.409) TCC e counselling efficaci, TCC potenzialmente costo-efficace. Meta-analisi su dati individuali: bambini/adolescenti T1DM (9 studi, 1.392) effetti principali per eta e durata del diabete; adulti T2DM (19 studi, 3.639) HbA1c basale moderatore dell'esito.
Cosa significa per teBussola: nel tipo 2 (adulti) gli interventi psicologici danno un beneficio piccolo e statisticamente significativo sull'HbA1c (circa -0,33%, cioe modesto sul piano clinico) e aiutano dieta e qualita di vita, ma non pressione, peso o umore; il livello di HbA1c di partenza incide sulla risposta (era un moderatore dell'esito, senza che l'abstract ne precisi la direzione). Nel tipo 1 (autoimmune), sia adulti sia bambini/adolescenti, non c'e prova di beneficio sull'HbA1c rispetto ai gruppi di controllo, anche se in eta pediatrica eta e durata di malattia contano. Utile come supporto complementare (soprattutto TCC), non come sostituto della gestione medica. La prova e una revisione sistematica ampia e ben condotta, ma gli effetti sono contenuti e nel tipo 1 sostanzialmente nulli sul controllo glicemico.
Abstract (in lingua originale)
BACKGROUND: For people with diabetes mellitus to achieve optimal glycaemic control, motivation to perform self-management is important. The research team wanted to determine whether or not psychological interventions are clinically effective and cost-effective in increasing self-management and improving glycaemic control. OBJECTIVES: The first objective was to determine the clinical effectiveness of psychological interventions for people with type 1 diabetes mellitus and people with type 2 diabetes mellitus so that they have improved (1) glycated haemoglobin levels, (2) diabetes self-management and (3) quality of life, and fewer depressive symptoms. The second objective was to determine the cost-effectiveness of psychological interventions. DATA SOURCES: The following databases were accessed (searches took place between 2003 and 2016): MEDLINE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library, PsycINFO, EMBASE, Cochrane Controlled Trials Register, Web of Science, and Dissertation Abstracts International. Diabetes conference abstracts, reference lists of included studies and Clinicaltrials.gov trial registry were also searched. REVIEW METHODS: Systematic review, aggregate meta-analysis, network meta-analysis, individual patient data meta-analysis and cost-effectiveness modelling were all used. Risk of bias of randomised and non-randomised controlled trials was assessed using the Cochrane Handbook (Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928). DESIGN: Systematic review, meta-analysis, cost-effectiveness analysis and patient and public consultation were all used. SETTING: Settings in primary or secondary care were included. PARTICIPANTS: Adolescents and children with type 1 diabetes mellitus and adults with types 1 and 2 diabetes mellitus were included. INTERVENTIONS: The interventions used were psychological treatments, including and not restricted to cognitive-behavioural therapy, counselling, family therapy and psychotherapy. MAIN OUTCOME MEASURES: Glycated haemoglobin levels, self-management behaviours, body mass index, blood pressure levels, depressive symptoms and quality of life were all used as outcome measures. RESULTS: A total of 96 studies were included in the systematic review (n = 18,659 participants). In random-effects meta-analysis, data on glycated haemoglobin levels were available for seven studies conducted in adults with type 1 diabetes mellitus (n = 851 participants) that demonstrated a pooled mean difference of -0.13 (95% confidence interval -0.33 to 0.07), a non-significant decrease in favour of psychological treatment; 18 studies conducted in adolescents/children with type 1 diabetes mellitus (n = 2583 participants) that demonstrated a pooled mean difference of 0.00 (95% confidence interval -0.18 to 0.18), indicating no change; and 49 studies conducted in adults with type 2 diabetes mellitus (n = 12,009 participants) that demonstrated a pooled mean difference of -0.21 (95% confidence interval -0.31 to -0.10), equivalent to reduction in glycated haemoglobin levels of -0.33% or ≈3.5 mmol/mol. For type 2 diabetes mellitus, there was evidence that psychological interventions improved dietary behaviour and quality of life but not blood pressure, body mass index or depressive symptoms. The results of the network meta-analysis, which considers direct and indirect effects of multiple treatment comparisons, suggest that, for adults with type 1 diabetes mellitus (7 studies; 968 participants), attention control and cognitive-behavioural therapy are clinically effective and cognitive-behavioural therapy is cost-effective. For adults with type 2 diabetes mellitus (49 studies; 12,409 participants), cognitive-behavioural therapy and counselling are effective and cognitive-behavioural therapy is potentially cost-effective. The results of the individual patient data meta-analysis for adolescents/children with type 1 diabetes mellitus (9 studies; 1392 participants) suggest that there were main effects for age and diabetes duration. For adults with type 2 diabetes mellitus (19 studies; 3639 participants), baseline glycated haemoglobin levels moderated treatment outcome. LIMITATIONS: Aggregate meta-analysis was limited to glycaemic control for type 1 diabetes mellitus. It was not possible to model cost-effectiveness for adolescents/children with type 1 diabetes mellitus and modelling for type 2 diabetes mellitus involved substantial uncertainty. The individual patient data meta-analysis included only 40-50% of studies. CONCLUSIONS: This review suggests that psychological treatments offer minimal clinical benefit in improving glycated haemoglobin levels for adults with type 2 diabetes mellitus. However, there was no evidence of benefit compared with control interventions in improving glycated haemoglobin levels for people with type 1 diabetes mellitus. FUTURE WORK: Future work should consider the competency of the interventionists delivering a therapy and psychological approaches that are matched to a person and their life course. STUDY REGISTRATION: This study is registered as PROSPERO CRD42016033619. FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 28. See the NIHR Journals Library website for further project information.
💬 Chiedi a LEO di spiegartelo
Come leggerlo: è uno studio scientifico peer-reviewed. Le evidenze aiutano a capire i trend, ma un singolo studio non è una prescrizione: parlane col tuo diabetologo prima di cambiare dieta o terapia.